Signal Genetics - 48 Year Dividend History | MGEN

Historical dividend payout and yield for Signal Genetics (MGEN) since 1971. The current TTM dividend payout for Signal Genetics (MGEN) as of April 18, 2019 is $0.00. The current dividend yield for Signal Genetics as of April 18, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.084B $0.008B
Miragen Therapeutics, Inc. is a biopharmaceutical company. It develops microRNA biology, oligonucleotide chemistry, drugs and therapies for cancer, pathologic fibrosis, neuro-inflammatory and cardiovascular diseases. Miragen Therapeutics, Inc., formerly known as Signal Genetics, is headquartered in Boulder, Colorado.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $109.312B 12.32
Gilead Sciences (GILD) United States $80.293B 10.22
Bio-Techne Corp (TECH) United States $7.144B 48.13